No Data
No Data
Press Release: Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar This Friday, March 22, 2024, at 4 Pm EST
Asep Medical Holdings Inc. to Hold Significant Investor Information Webinar this Friday, March 22, 2024, at 4 pm EST Canada NewsWire VANCOUVER, BC, March 18, 2024 CLICK HERE TO REGISTER VANCOUVER,
Update: ASEP Medical Holdings Reports Settlement of Debt; Down 6.8%
ASEP Medical Holdings Inc. (ASEP.CSE) overnight Thursday reported the issuance of shares for debt settlement. The company has issued about 3.9 million units at a deemed price of $0.20 per unit in a se
ASEP Medical Holdings Reports Settlement of Debt
ASEP Medical Holdings Inc. (ASEP.CSE) overnight Thursday reported the issuance of shares for debt settlement. The company has issued about 3.9 million units at a deemed price of $0.20 per unit in a se
ASEP Medical Holdings Granted Patent Approval for Its AI-based Sepsis Diagnostic Technology in the US
ASEP Medical Holdings Inc. (ASEP.CSE), which gained 20% on Friday over the weekend announced that its AI-based sepsis diagnostic technology, called SepsetER, has received patent approval in the United
Asep Medical Holdings Inc. Is Granted Patent Approval for Its AI-based Sepsis Diagnostic Technology in the US
VANCOUVER, BC, Nov. 24, 2023 /PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that the Company's AI-based sepsis d
Asep Inc. Obtains Exclusive Worldwide License From the University of British Columbia for Ground-breaking Medical Device Coating Technology
VANCOUVER, BC, July 31, 2023 /CNW/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) is pleased to announce that, as of July 21, 2023, it has completed the final milestone in its acquisition of SafeCoat Medical Inc. ("SafeCoat") and entered into an exclusive worldwide license agreement (the "Agreement") with the University of British Columbia ("UBC"), through its subsidiary SafeCoat, for the use, development and commercialization of a ground-breaking medical device coating technology (the "Technology").